Biochemical, Biological, and Clinical Properties of γ-Oryzanol
Antioxidants · 09.09.2025 · 14 (9) · 1099
DOI: 10.3390/antiox14091099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 09.09.2025. Verfasst von Helena Juricic und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP), Mission 4, Component 2, Investment 1.1, Call for tender No. 104 published on 2.2.2022 by the Italian Ministry of…, National Recovery and Resilience Plan (NRRP), European Union—NextGenerationEU.
Abstract (Originalsprache)
γ-Oryzanol is a complex mixture of ferulic acid esters of phytosterols and triterpene alcohols predominantly found in rice bran. It exhibits a wide range of biological activities, including antioxidant, anti-inflammatory, and lipid-lowering effects, as well as the ability to modulate cellular metabolic pathways in both in vitro and in vivo models. The composition and concentration of γ-oryzanol vary significantly among rice varieties and are influenced by genetic, environmental, and technological factors. Advances in extraction methods, including traditional solvent extraction and innovative approaches such as supercritical fluid extraction, have improved yield and purity, supporting its use in functional foods, nutraceuticals, and cosmetics. Current research in the biological, biomedical, and cosmetic fields is actively investigating γ-oryzanol’s mechanisms of action in metabolic regulation and inflammation, as well as developing advanced formulation strategies to enhance its antioxidant, skin-protective, and functional properties. These efforts aim to optimize its delivery and efficacy by addressing challenges related to poor water solubility and bioavailability, thereby expanding its role as a multifunctional bioactive compound. This review provides a comprehensive overview on γ-oryzanol, focusing on its extraction techniques, chemical characterization, and biological/pharmacological activities. Additionally, clinical trials investigating its efficacy and safety have been thoroughly dissected, offering valuable insights into its therapeutic potential in human populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy.
- Division of Pharmacology-Department of Molecular and Traslational Medicine, University of Brescia, 25123 Brescia, Italy.
ORCID-Profile: Massimiliano Cuccioloni, Laura Bonfili, Mauro Angeletti, Daniela Uberti, Anna Maria Eleuteri, Giulia Abate, Valentina Cecarini
Förderung
- National Recovery and Resilience Plan (NRRP), Mission 4, Component 2, Investment 1.1, Call for tender No. 104 published on 2.2.2022 by the Italian Ministry of…
- National Recovery and Resilience Plan (NRRP)
- European Union—NextGenerationEU
Zitieren
APA
Juricic, H., Cuccioloni, M., Bonfili, L., Angeletti, M., Uberti, D., Eleuteri, A. M., Abate, G., & Cecarini, V. (2025). Biochemical, Biological, and Clinical Properties of γ-Oryzanol. Antioxidants, 14(9), 1099. https://doi.org/10.3390/antiox14091099
Vancouver
Juricic H, Cuccioloni M, Bonfili L, Angeletti M, Uberti D, Eleuteri AM, et al. Biochemical, Biological, and Clinical Properties of γ-Oryzanol. Antioxidants. 2025;14(9):1099. doi:10.3390/antiox14091099
BibTeX
@article{Juricic2025,
author = {Juricic, Helena and Cuccioloni, Massimiliano and Bonfili, Laura and Angeletti, Mauro and Uberti, Daniela and Eleuteri, Anna Maria and Abate, Giulia and Cecarini, Valentina},
title = {Biochemical, Biological, and Clinical Properties of γ-Oryzanol},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {9},
pages = {1099},
doi = {10.3390/antiox14091099}
}
EUVIMED